Clinical Application of Blood Glucose and Urine Glucose Test in the Diagnosis of Diabetes Mellitus

2021 ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Clinical Application ◽  
Urine Glucose ◽  
Glucose Test ◽  
Diagnosis Of Diabetes Mellitus

scholarly journals Factors Associated with Adherence to Blood Glucose Test among Diabetes Mellitus Patients at Prof. Dr. W. Z. Johannes Hospital, Kupang

2016 ◽  
Vol 01 (01) ◽  
pp. 12-19
Author(s):  
Dessy Nelciani Timuneno ◽  
◽  
Deviarbi Sakke Tira ◽  
Imelda F. E Manurung ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Factors Associated ◽  
Blood Glucose Test ◽  
Glucose Test

„Neues und Kontroverses zur Blutglukosemessung bei der Diabetesdiagnostik: Konsequenzen der aktualisierten DDG- und AWMF-Leitlinien“/“Blood glucose measurement for the diagnosis of diabetes mellitus: new and controversial consequences of updated DDG and AWMF guidelines”

2012 ◽  
Vol 36 (3) ◽  
Author(s):  
Theodor Koschinsky ◽  
Peter B. Luppa
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Blood Glucose Measurement ◽  
Glucose Measurement ◽  
Diagnosis Of Diabetes Mellitus

ZusammenfassungFür die Durchführung und Bewertung der Blutglukose (BG)-Messung bei der primären Diabetesdiagnostik sind neue DDG (Deutsche Diabetes-Gesellschaft)- und AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften)-Leitlinien-Standards festgelegt worden. Diese betreffen folgende Bereiche: Abgrenzung zur HbA

Blood glucose measurement for the diagnosis of diabetes mellitus: new and controversial consequences of updated DDG (German Diabetes Society)- and AWMF (Association of the Scientific Medical Societies)-guidelines1)

2013 ◽  
Vol 36 (2) ◽  
Author(s):  
Theodor Koschinsky ◽  
Peter B. Luppa
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Gestational Diabetes ◽  
Blood Glucose Measurement ◽  
Glucose Measurement ◽  
Medical Societies ◽  
German Diabetes ◽  
Diagnosis Of Diabetes Mellitus

AbstractNew DDG (Deutsche Diabetes-Gesellschaft) and AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften) guidelines have been established for the diagnosis of diabetes mellitus and gestational diabetes. These are relevant for blood glucose (BG) measurements with reference to: distinction from HbA

Random capillary whole blood glucose test as a screening test for diabetes mellitus in an elderly population

1995 ◽  
Vol 5 (4) ◽  
pp. 277-280
Author(s):  
QING QLAO ◽  
LIISA HIL TUNEN ◽  
SIRKKA KEINA¨NEN-KIUKAANNIEMI ◽  
KEIJO KOSKI ◽  
HEIKKI LUUKINEN ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Whole Blood ◽  
Screening Test ◽  
Elderly Population ◽  
Blood Glucose Test ◽  
Glucose Test

scholarly journals TELAAH KOMPREHENSIF DIABETES MELITUS: KLASIFIKASI, GEJALA, DIAGNOSIS, PENCEGAHAN, DAN PENGOBATAN

2021 ◽  
Vol 7 (2) ◽  
pp. 304-317
Author(s):  
Dudi Hardianto
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Plasma Glucose ◽  
Genetic Disorders ◽  
Medical Intervention ◽  
Oral Glucose ◽  
Glucose Levels ◽  
Blood Glucose Test ◽  
Glucose Test ◽  
Diabetes Melitus

Diabetes mellitus is a metabolic disorder characterized by hyperglycemia. In general, diabetes is classified into type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational, and other specific diabetes. The causes of diabetes are genetic disorders and environmental. Common symptoms of diabetes include: polydipsia, polyphagia, glycosuria, polyuria, dehydration, fatigue, weight loss, reduced vision, cramps, constipation, and candida infection. Test for diagnosis of diabetes include: fasting plasma glucose test, plasma glucose test after 2 hours of 75 g oral glucose administration, the glycated hemoglobin test (HbA1C), and random blood glucose test. Prevention of T1DM is still difficult because of the limited knowledge of metabolic, genetic, and immunological processes in the development of T1DM. T2DM is prevented by lifestyle and medical intervention. Insulin is the only drug for T1DM, whereas T2DM is treated with metformin as drug’s primary choice for reducing blood glucose levels. Diabetes melitus merupakan penyakit kelainan metabolisme yang ditandai dengan hiperglikemia. Secara umum, diabetes diklasifikasikan menjadi: diabetes melitus tipe 1 (DMT1), diabetes melitus tipe 2 (DMT2), gestasional, dan diabetes spesifik lain. Penyebab diabetes adalah kelainan genetik dan lingkungan. Gejala umum diabetes antara lain: polidipsia, polifagia, glikosuria, poliuria, dehidrasi, kelelahan, penurunan berat badan, daya penglihatan berkurang, kram, konstipasi, dan infeksi candida. Pemeriksaaan untuk diagnosis diabetes meliputi: pemeriksaan glukosa plasma saat puasa, pemeriksaan glukosa plasma setelah 2 jam pemberian glukosa oral 75 g, pemeriksaan hemoglobin terglikasi (HbA1C), dan pemeriksaan glukosa darah acak. Pencegahan DMT1 masih sulit karena terbatasnya pengetahuan proses metabolisme, genetik, dan imunologi pada perkembangan DMT1. DMT2 dicegah dengan intervensi gaya hidup dan intervensi medis. Insulin merupakan satu-satunya obat untuk DMT1, sedangkan DMT2 diobati dengan metformin sebagai pilihan utama dan non obat untuk menurunkan kadar glukosa dalam darah.

scholarly journals Differences in self-monitored, blood glucose test strip utilization by therapy for type 2 diabetes mellitus

2016 ◽  
Vol 53 (3) ◽  
pp. 483-492 ◽  
Author(s):  
Ruben Tavares ◽  
Marc Duclos ◽  
Marie-Josée Brabant ◽  
Daniella Checchin ◽  
Nevzeta Bosnic ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Blood Glucose ◽  
Test Strip ◽  
Blood Glucose Test ◽  
Glucose Test

scholarly journals Diagnostic accuracy of self-administered urine glucose test strips as a diabetes screening tool in a low-resource setting in Cambodia

BMJ Open ◽  
2018 ◽  
Vol 8 (3) ◽  
pp. e019924 ◽  
Author(s):  
Helen, L Storey ◽  
Maurits H van Pelt ◽  
Socheath Bun ◽  
Frances Daily ◽  
Tina Neogi ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Venous Blood ◽  
Fasting Blood Glucose ◽  
Test Strip ◽  
Diabetes Screening ◽  
Urine Glucose ◽  
Low Resource ◽  
Resource Setting ◽  
Low Resource Setting ◽  
Glucose Test

ObjectiveScreening for diabetes in low-resource countries is a growing challenge, necessitating tests that are resource and context appropriate. The aim of this study was to determine the diagnostic accuracy of a self-administered urine glucose test strip compared with alternative diabetes screening tools in a low-resource setting of Cambodia.DesignProspective cross-sectional study.SettingMembers of the Borey Santepheap Community in Cambodia (Phnom Penh Municipality, District Dangkao, Commune Chom Chao).ParticipantsAll households on randomly selected streets were invited to participate, and adults at least 18 years of age living in the study area were eligible for inclusion.OutcomesThe accuracy of self-administered urine glucose test strip positivity, Hemoglobin A1c (HbA1c)>6.5% and capillary fasting blood glucose (cFBG) measurement ≥126 mg/dL were assessed against a composite reference standard of cFBGmeasurement ≥200 mg/dL or venous blood glucose 2 hours after oral glucose tolerance test (OGTT) ≥200 mg/dL.ResultsOf the 1289 participants, 234 (18%) had diabetes based on either cFBG measurement (74, 32%) or the OGTT (160, 68%). The urine glucose test strip was 14% sensitive and 99% specific and failed to identify 201 individuals with diabetes while falsely identifying 7 without diabetes. Those missed by the urine glucose test strip had lower venous fasting blood glucose, lower venous blood glucose 2 hours after OGTT and lower HbA1c compared with those correctly diagnosed.ConclusionsLow cost, easy to use diabetes tools are essential for low-resource communities with minimal infrastructure. While the urine glucose test strip may identify persons with diabetes that might otherwise go undiagnosed in these settings, its poor sensitivity cannot be ignored. The massive burden of diabetes in low-resource settings demands improvements in test technologies.

Sign in / Sign up

Export Citation Format

Share Document